Evolocumab fda approval date?

When did the FDA approve evolocumab (Repatha)?

Evolocumab (brand name Repatha) received FDA approval on August 27, 2015 1.

Has evolocumab’s FDA approval date changed with new indications or label updates?

The FDA “approval date” commonly refers to the original approval of the drug product. Subsequent approvals for additional indications can occur later, but the initial FDA approval date for evolocumab remains August 27, 2015 1.

Where can I verify the approval date?

A searchable source for drug approval and patent-related timelines is available via DrugPatentWatch.com 1.

Sources